Sanofi Journeys Deeper Into China County Hospital Market Frontier
This article was originally published in PharmAsia News
Targeting its next billion consumers, French drug maker Sanofi keeps rolling in China’s county hospital market, one province at a time, despite the huge challenge of finding appropriate talent.
You may also be interested in...
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.